| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 13.31K | C$ 15.57K | C$ 39.57K | C$ 32.13K | C$ 40.89K |
| Gross Profit | C$ 8.13K | C$ 9.34K | C$ 33.70K | C$ 25.28K | C$ -57.46K |
| Operating Income | C$ -136.91K | C$ -114.51K | C$ -250.45K | C$ -111.90K | - |
| EBITDA | C$ -136.91K | C$ -114.51K | C$ -250.41K | C$ -107.63K | C$ 22.20K |
| Net Income | C$ -139.93K | C$ -116.29K | C$ -252.18K | C$ -114.12K | C$ -280.28K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 13.24K | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Total Assets | C$ 107.95K | C$ 144.08K | C$ 166.93K | C$ 182.04K | C$ 218.65K |
| Total Debt | C$ 1.47M | C$ 1.32M | C$ 1.25M | C$ 1.04M | C$ 973.51K |
| Net Debt | C$ 1.45M | C$ 1.32M | C$ 1.25M | C$ 1.04M | C$ 973.51K |
| Total Liabilities | C$ 1.89M | C$ 1.77M | C$ 1.68M | C$ 1.56M | C$ 1.44M |
| Stockholders' Equity | C$ -1.78M | C$ -1.62M | C$ -1.52M | C$ -1.38M | C$ -1.22M |
| Cash Flow | |||||
| Free Cash Flow | C$ -168.21K | C$ -66.30K | C$ -111.11K | C$ -12.22K | C$ -114.33K |
| Operating Cash Flow | C$ -168.21K | C$ -66.30K | C$ -111.00K | C$ -6.54K | C$ -114.33K |
| Investing Cash Flow | C$ 0.00 | C$ 0.00 | C$ -109.00 | C$ -5.68K | C$ 0.00 |
| Financing Cash Flow | C$ 181.16K | C$ 63.10K | C$ 91.61K | C$ 12.22K | C$ 114.33K |
Lamperd Less Lethal Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.